CoChat

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Background: Insulin resistance (IR) is a potential predictor of antidepressant treatment response. Aims: We assess changes in IR after antidepressant treatment and whether these changes have any effect on treatment response. Also, to see whether changes in IR mediates relationship between C-reactive protein (CRP) and antidepressant efficacy. Methods: This is a secondary analysis of an 8-week, open-label clinical trial with 95 adults experiencing a major depressive episode. Response to vortioxetine was measured using the Montgomery–Åsberg Depression Rating Scale (MADRS). Generalized estimating equation models were utilized for this intent-to-treat analysis. Results: When adjusted for age, sex, and body mass index, there was a significant increase in IR following treatment in the overall sample (p = 0.035). This finding was detected in treatment non-responders (p = 0.019), whereas it was not observed in responders (p = 0.329). Mediation analysis revealed that change in IR during treatment was responsible for change in MADRS as well as the relationship between baseline CRP and treatment response. Conclusions: Exacerbation of IR during antidepressant treatment mediated non-response. Conversely in treatment responders IR reduced. Like previous studies, baseline CRP moderated treatment response. This relationship was also mediated by changes in IR. These findings further elucidate the role of IR in terms of antidepressant response as well as potentially explain inflammation’s relationship with the latter.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/02698811221132473

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Baseline and endpoint estimated means and standard errors of insulin resistance (HOMA2-IR) values, according to treatment response. HOMA-IR: homeostatic model assessment of insulin resistance.
Figure 1. Baseline and endpoint estimated means and standard errors of insulin resistance (HOMA2-IR) values, according to treatment response. HOMA-IR: homeostatic model assessment of insulin resistance.CC BY · PubMed Central
Figure 2. Unstandardized regression coefficients from a bootstrap-mediation analysis indicating that percentage changes in insulin resistance fully mediated the effects of baseline CRP on percentage changes in depressive symptoms severity following treatment. CRP: C-reactive protein.
Figure 2. Unstandardized regression coefficients from a bootstrap-mediation analysis indicating that percentage changes in insulin resistance fully mediated the effects of baseline CRP on percentage changes in depressive symptoms severity following treatment. CRP: C-reactive protein.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 23

Metadata

Authors
Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., Iacobucci, M., Jaberi, S., Rosenblat, J. D., McIntyre, R. S., & Mansur, R. B.
Affiliations
  • University Health Network (CA)
  • Southwest University (CN)
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario
Corresponding author
Rashidian, Houman
Venue
Journal of Psychopharmacology
Published
2022-11-15
Volume
37
Issue
3
Pages
313-317
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W4309099433
Cited by
23
References
24
Citations by year
2026: 5 · 2025: 5 · 2024: 10 · 2023: 3
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Brain and Cognition Discovery Foundation by Lundbeck, Denmark
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
insulin resistance, antidepressant response, major depressive disorder, vortioxetine, C-reactive protein, inflammation, mediation analysis, treatment non-responders
MeSH terms
Vortioxetine, Adult, Antidepressive Agents, C-Reactive Protein, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Humans, Insulin Resistance, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. https://app.cochat.ai/papers/10.1177/02698811221132473
The paper
Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., Iacobucci, M., Jaberi, S., Rosenblat, J. D., McIntyre, R. S., & Mansur, R. B. (2023). Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. Journal of Psychopharmacology. https://doi.org/10.1177/02698811221132473

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.